EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models

Victoria Laney, Ryan Hall, Xueer Yuan, Emma Hampson, Augusta Halle, Grace Yeung, Kristen-Weber Bonk, Suneel Apte, Jordan Winter, Ruth Keri, Zheng-Rong Lu

Pharmaceutical Research · 2024

DOI: 10.1007/s11095-024-03762-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, 2024. Verfasst von Victoria Laney und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Case Western Reserve University, Wickenden 427, 10900 Euclid Avenue, Cleveland, OH, 44106, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, MicroRNAs, Carcinoma, Pancreatic Ductal, Magnetic Resonance Imaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pancreatic ductal adenocarcinoma (PDAC) is characterized by desmoplasia due to increased deposition of extracellular matrix (ECM) proteins. This work investigates the efficacy of targeted ECO/miR-200c nanoparticles (ELNP) on ECM remodeling in PDAC and tumor proliferation with MR molecular imaging (MRMI) with MT218 in immunocompetent mouse models.

Methods

The miR-200c mediated regulation of EMT markers was measured in PDAC cells in vitro . Wild-type mice bearing mutated KRAS-driven KPC subcutaneous or orthotopic tumors were dosed weekly with RGD-ELNP/miR-200c at 1 mg-RNA/kg for a total of 4 doses. We utilized MT218-MRMI to non-invasively monitor the alteration of tumor ECM EDN-FN levels by miR-200c and tumor response to the treatment. The changes were also validated by posthumous histopathology.

Results

Transfection of PDAC cells with ELNP/miR-200c downregulated the expression of FN1 and EDB-FN and some mesenchymal markers, inhibiting 3D spheroid formation and migration of KPC PDAC cells. RGD-ELNP/miR-200c treatment resulted in significant signal reduction in the MT218 enhanced MRMI images of both subcutaneous and orthotopic KPC tumors compared to those prior to treatment and treated with a non-specific control. MT218-MRMI results were suggestive of EDB-FN downregulation in tumors, which was later confirmed by immunohistochemistry. Tumor growth in subcutaneous tumors was significantly attenuated with RGD-ELNP/miR-200c and was an observed trend in orthotopic tumors. Substantial necrosis and remodeling were observed in both models treated with RGD-ELNP/miR-200c based on H&E staining.

Conclusion

These results demonstrate the feasibility of RGD-ELNP/miR-200c in modulating PDAC ECM and restraining tumor growth and the utility of MT218-MRMI for non-invasively monitoring miR-200c efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsMicroRNAsCarcinoma, Pancreatic DuctalMagnetic Resonance ImagingNanoparticlesAnimalsMiceCell Line, TumorHumansMolecular ImagingDisease Models, AnimalCell Proliferation

Stichwörter der Autor:innen

ECOMT218magnetic resonance molecular imagingmiR-200cpancreatic cancer

Substanzen

MicroRNAsMirn200 microRNA, mouse

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Case Western Reserve University, Wickenden 427, 10900 Euclid Avenue, Cleveland, OH, 44106, USA.
  • Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44106, USA.
  • Surgical Oncology, The University Hospitals of Cleveland, Cleveland, OH, 44106, USA.
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Department of Biomedical Engineering, Case Western Reserve University, Wickenden 427, 10900 Euclid Avenue, Cleveland, OH, 44106, USA. zxl125@case.edu.
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, 44106, USA. zxl125@case.edu.

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Laney, V., Hall, R., Yuan, X., Hampson, E., Halle, A., Yeung, G., Bonk, K. W., Apte, S., Winter, J., Keri, R., & Lu, Z. R. (2024). MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03762-7

Vancouver

Laney V, Hall R, Yuan X, Hampson E, Halle A, Yeung G, et al. MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models. Pharmaceutical Research. 2024. doi:10.1007/s11095-024-03762-7

BibTeX
@article{Laney2024,
  author = {Laney, Victoria and Hall, Ryan and Yuan, Xueer and Hampson, Emma and Halle, Augusta and Yeung, Grace and Bonk, Kristen-Weber and Apte, Suneel and Winter, Jordan and Keri, Ruth and Lu, Zheng-Rong},
  title = {MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models},
  journal = {Pharmaceutical Research},
  year = {2024},
  doi = {10.1007/s11095-024-03762-7}
}
Kostenlos starten →